Martha Gschwandtner

3PUBLICATIONS
11CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 14, 2025
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux.

Martha Gschwandtner, Rupert Derler, Elisa Talker

|Oct 14, 2023
Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration.

Alissa Domaingo, Philipp Jokesch, Alexandra Schweiger

|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.

Martha Gschwandtner, Anís N Gammage, Claire Deligne

Pageof 1